Global Rare Disease Market worth US$623.73 Billion by 2031: Visiongain Research, Inc.
15. Juni 2021 12:00 ET
|
Visiongain Ltd
Visiongain has published a new report on “Rare Disease Market Forecast 2021-2031: By Drugs (Revlimid, MabThera/Rituxan, Opdivo, Imbruvica, Sprycel, Tasigna, Copaxone,Rebif, Gleevec, Velcade, Others),...